Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Enrolling by invitation 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Infections 1

Interventions

pembrolizumab 1251Specimen Handling 867Carboplatin 816Magnetic Resonance Spectroscopy 803Cyclophosphamide 794Cisplatin 715Nivolumab 646Paclitaxel 623Radiotherapy 564Gemcitabine 562Biopsy 529Bevacizumab 468Dexamethasone 433fludarabine 404Docetaxel 370venetoclax 365Oxaliplatin 362Fluorouracil 352Capecitabine 350atezolizumab 341Rituximab 326durvalumab 326Doxorubicin 313Radiosurgery 305Pemetrexed 302Drug Therapy 294Standard of Care 292Ipilimumab 289Etoposide 279Radiation 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Antibiotic Prophylaxis × 1 year × Clear all
NCT07557901 2026-05-15

A Study Comparing Infectious Complications After Transperineal Prostate Biopsy With or Without Antibiotic Prophylaxis

F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica

Phase NA Enrolling by invitation
300 enrolled
Genitourinary

Prostatic Neoplasms

NCT04815876 2026-02-20

PREVENT2

Weill Medical College of Cornell University

Phase NA Completed
1,030 enrolled
Genitourinary

Infections, Prostatic Neoplasms

NCT01407263 2025-08-14

Trial of Modifications to Radical Prostatectomy

Memorial Sloan Kettering Cancer Center

Phase 3 Active not recruiting
3,204 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡